Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Tomi Environmental Solutions Nasdaq/NYSE Compliance Notice
TOMI Environmental Solutions has regained compliance with Nasdaq's minimum bid price and stockholders' equity requirements, allowing its common stock to continue listing under the symbol 'TOMZ'. The company will be subject to a one-year discretionary monitor by the Nasdaq Hearings Panel beginning September 2, 2026, during which any subsequent noncompliance with equity requirements will result in immediate delisting.
Brand Engagement Network Inc. notified Nasdaq of its non-compliance with multiple listing rules, including requirements for timely periodic reporting, audit and compensation committee composition, and oversight of related party transactions. The company also identified potential non-compliance regarding shareholder approval for equity compensation arrangements. The company has 45 days to submit a plan to regain compliance, which if accepted, could grant an extension of up to 180 days.
Cable One received a deficiency notice from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement. The company has 45 days to submit a plan to regain compliance within an 18-month cure period. Additionally, the company disclosed it missed a $10 million interest payment on its 4.00% senior notes due 2030, entering a 30-day grace period.
XMAX Inc. received a Letter of Reprimand from Nasdaq for failing to obtain shareholder approval prior to issuing more than 20% of its common stock at a discount to the minimum price. Nasdaq determined that delisting was not an appropriate sanction because shareholders subsequently ratified the issuances at a special meeting on November 2, 2026. The matter is now closed and the company's common stock continues to trade on the Nasdaq Stock Market.
Lakewood-Amedex Biotherapeutics received a delisting notice from Nasdaq on November 10, 2026, because its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Due to a prior reverse stock split within the last year, the company is ineligible for a standard compliance period and faces immediate suspension unless it successfully appeals to a Nasdaq Hearings Panel. The company intends to request a hearing to stay the delisting and present a plan to regain compliance.
Connect Biopharma received a deficiency notice from Nasdaq on November 12, 2026, because its ordinary shares closed below the $1.00 minimum bid price requirement for 30 consecutive business days. The company has until May 11, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least ten consecutive business days. The notice has no immediate effect on the listing of the company's shares, which continue to trade under the symbol 'CNTB'.
Counterparty
Nasdaq
Term
180 days
“We believe topline results from our Phase 2 Seabreeze STAT asthma and COPD studies mark a significant inflection point in the development of rademikibart as an add-on treatment to rescue bronchodilators and systemic corticosteroids for the treatment of acute exacerbations.”
Barry Quart, Pharm.D., CEO and Director of Connect Biopharma
“We believe these findings support the potential of rademikibart to redefine how acute exacerbations are managed, addressing both the acute event and the 4-week high-risk period following an exacerbation, to improve patient outcomes and reduce the substantial economic burden on healthcare systems.”
Barry Quart, Pharm.D., CEO and Director of Connect Biopharma
KALA BIO received a determination from the Nasdaq Hearings Panel granting its request to continue its listing on The Nasdaq Capital Market subject to specific conditions. The company must evidence a closing bid price of at least $1.00 per share for ten consecutive business days by November 30, 2026, and maintain that price through February 23, 2027. Failure to meet these conditions or any other listing rules during this period may result in delisting.
Flux Power Holdings received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company has until December 24, 2026, to submit a plan to regain compliance and is also working to meet an extended December 4 deadline for a $4.0 million equity raise required by its lender, Gibraltar Business Capital.
Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.
Q/C Technologies received a deficiency notice from Nasdaq on November 6, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, or until May 5, 2027, to regain compliance with the minimum bid price requirement. If compliance is not regained, the company may be eligible for an additional 180-day period or face delisting.
Singularity Future Technology received a delisting notice from Nasdaq on November 10, 2026, because its stock price remained below the $1.00 minimum bid requirement for 30 consecutive business days. Because the company completed a reverse stock split within the past year, it is ineligible for a standard 180-day grace period and faces immediate suspension unless it successfully appeals to a Nasdaq Hearings Panel. Separately, shareholders approved the future issuance of 250 million shares and approximately 6.9 million warrants at a special meeting.
CN Healthy Food Tech Group Nasdaq/NYSE Compliance Notice
CN Healthy Food Tech Group Corp. received an additional delisting determination from Nasdaq on November 9, 2026, following allegations from the China Securities Regulatory Commission (CSRC) regarding filing compliance and the authenticity of materials provided to Nasdaq. The company's common stock and warrants remain halted from trading while the Nasdaq Hearings Panel considers the matter. The company has until November 16, 2026, to provide a written response to the Panel to address these additional deficiencies.
Greenland Technologies received a deficiency notice from Nasdaq because its Class A ordinary shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 share price for at least 10 consecutive business days. The company is considering options to cure the deficiency, including a potential share consolidation (reverse stock split).
The NYSE has commenced proceedings to delist PSQ Holdings' Class A common stock and public warrants after the company failed to maintain a minimum average global market capitalization of $15 million. Trading on the NYSE was suspended immediately on November 9, 2026, and the securities transitioned to the Pink Limited Market. The company does not intend to appeal the delisting determination and is seeking a listing on the OTCQB Venture Market.
Creative Medical Technology Holdings Nasdaq/NYSE Compliance Notice
Creative Medical Technology Holdings received a deficiency notice from Nasdaq on November 10, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until May 10, 2027, to regain compliance by having its stock close at or above $1.00 for at least ten consecutive business days. The notice has no immediate impact on the listing of the company's common stock (CELZ).
NextNRG, Inc. received a final determination from the Nasdaq Hearings Panel to delist its common stock after failing to meet the $1.00 minimum bid price and $35 million market value requirements. Trading on Nasdaq was suspended effective November 12, 2026, and the company's shares began quoting on the OTC Markets under the symbol 'NXXT'.
aTyr Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock closed at or above $1.00 per share for 10 consecutive business days. The company had previously been under a deficiency notice since December 2025 and was granted an extension until November 30, 2026, to meet the standard. As of this filing, the company has no outstanding deficiency notices from Nasdaq.
Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.
Loop Industries received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum Market Value of Publicly Held Shares (MVPHS) of $15 million for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a MVPHS of at least $15 million for ten consecutive business days. The notice does not have an immediate effect on the listing of the company's common stock.
Beeline Holdings received a deficiency notice from Nasdaq on November 6, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until May 5, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days.
FreeCast, Inc. notified Nasdaq that it is no longer in compliance with Audit Committee composition requirements following the immediate resignation of director William P. Jennings, Jr. on November 6, 2026. The company intends to restore compliance by appointing a replacement candidate as director and Audit Committee Chairperson effective November 17, 2026.
Beneficient received a deficiency notice from Nasdaq on November 5, 2026, because its market value of listed securities (MVLS) fell below the $35 million minimum requirement for 30 consecutive business days. The company has until May 4, 2027, to regain compliance by maintaining an MVLS of at least $35 million for at least ten consecutive business days. The notice has no immediate effect on the listing of the company's Class A common stock (BENF) or warrants (BENFW).
Rain Enhancement Technologies Holdco received a deficiency notice from Nasdaq on November 6, 2026, because its Class A common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until May 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least ten consecutive business days.
Rani Therapeutics received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement. As part of this process, the company's listing was transferred from the Nasdaq Global Market to the Nasdaq Capital Market effective November 12, 2026. The company now has until May 10, 2027, to meet the requirement, which may involve a reverse stock split if necessary.
Hydrofarm Holdings Group Nasdaq/NYSE Compliance Notice
Hydrofarm Holdings Group, Inc. has regained compliance with Nasdaq's $2.5 million minimum stockholders’ equity requirement following a financial restructuring that eliminated $109 million in debt. The company remains subject to a Mandatory Panel Monitor for one year, during which any failure to satisfy the equity rule would result in an immediate delist notice without the opportunity to submit a new compliance plan.
Counterparty
Nasdaq
Term
through November 9, 2027
“We received notice from Nasdaq that we are in compliance on our stockholders’ equity, another milestone in our financial restructuring. With this confirmation, our organization is focused on profitable growth: our proprietary brands out of Eugene, the direct commercial sales channel that opened when the term loan was eliminated, and scaling logistics services under Project Agility. That’s where our 50th year starts.”
AtlasClear Holdings received notice from NYSE American that the exchange has suspended trading of its common stock and commenced delisting proceedings due to a low selling price. The company intends to appeal the determination and expects its stock to begin trading on the OTC Pink Limited Market on November 11, 2026.
Rent the Runway received a deficiency notice from Nasdaq on November 4, 2026, because its market value of publicly held shares (MVPHS) fell below the $15 million minimum requirement for 39 consecutive business days. The company has 180 calendar days, until May 3, 2027, to regain compliance by maintaining a MVPHS of at least $15 million for ten consecutive business days. The company is evaluating options to resolve the deficiency, including a potential transfer to The Nasdaq Capital Market.
NextNRG, Inc. received notice that the Nasdaq Hearings Panel denied its request to continue its listing on Nasdaq due to failure to meet the $1.00 minimum bid price and $35 million market value requirements. Trading of the company's common stock will be suspended on November 11, 2026, and is expected to transition to the OTC Markets under the symbol 'NXXT'.
Launch One Acquisition Nasdaq/NYSE Compliance Notice
Launch One Acquisition Corp. received a deficiency notice from Nasdaq for failing to meet audit committee composition and board independence requirements following the resignation of director Dr. Rodney A. Ferguson. The company has been granted a cure period until its next annual meeting or one year from the vacancy to appoint a new independent director and regain compliance.
Future Vision II Acquisition Nasdaq/NYSE Compliance Notice
Future Vision II Acquisition Corp. received notification from Nasdaq on November 5, 2026, confirming that the company has regained compliance with the minimum public holders requirement under Nasdaq Listing Rule 5550(a)(3). Nasdaq has determined the company now complies with the rule and has officially closed the matter.